| An update on pharmacological potential of boswellic acids against chronic diseases NK Roy, D Parama, K Banik, D Bordoloi, AK Devi, KK Thakur, ... International journal of molecular sciences 20 (17), 4101, 2019 | 190 | 2019 |
| Targeting AKT/mTOR in oral cancer: mechanisms and advances in clinical trials C Harsha, K Banik, HL Ang, S Girisa, R Vikkurthi, D Parama, V Rana, ... International journal of molecular sciences 21 (9), 3285, 2020 | 144 | 2020 |
| Inflammation, NF-κB, and chronic diseases: how are they linked? AB Kunnumakkara, B Shabnam, S Girisa, C Harsha, K Banik, TB Devi, ... Critical Reviews™ in Immunology 40 (1), 2020 | 129 | 2020 |
| COVID-19, cytokines, inflammation, and spices: How are they related? AB Kunnumakkara, V Rana, D Parama, K Banik, S Girisa, S Henamayee, ... Life sciences 284, 119201, 2021 | 111 | 2021 |
| Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases D Parama, M Boruah, K Yachna, V Rana, K Banik, C Harsha, KK Thakur, ... Life sciences 260, 118182, 2020 | 101 | 2020 |
| Direct electrochemical reduction of hematite decorated graphene oxide (α-Fe2O3@ erGO) nanocomposite for selective detection of Parkinson's disease biomarker G Mathew, P Dey, R Das, SD Chowdhury, MP Das, P Veluswamy, ... Biosensors and Bioelectronics 115, 53-60, 2018 | 83 | 2018 |
| Wogonin and its analogs for the prevention and treatment of cancer: A systematic review K Banik, E Khatoon, C Harsha, V Rana, D Parama, KK Thakur, ... Phytotherapy Research 36 (5), 1854-1883, 2022 | 69 | 2022 |
| Rationalizing the therapeutic potential of apigenin against cancer SA Ahmed, D Parama, E Daimari, S Girisa, K Banik, C Harsha, U Dutta, ... Life Sciences 267, 118814, 2021 | 67 | 2021 |
| Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer S Girisa, S Henamayee, D Parama, V Rana, U Dutta, AB Kunnumakkara Molecular biomedicine 2, 1-23, 2021 | 40 | 2021 |
| Role of turmeric and curcumin in prevention and treatment of chronic diseases: Lessons learned from clinical trials AB Kunnumakkara, M Hegde, D Parama, S Girisa, A Kumar, UD Daimary, ... ACS Pharmacology & Translational Science 6 (4), 447-518, 2023 | 34 | 2023 |
| Current clinical developments in curcumin-based therapeutics for cancer and chronic diseases ABK Aviral Kumar, Choudhary Harsha, Dey Parama, Sosmitha Girisa, Uzni Devi ... Phytotherapy Research, 2021 | 31 | 2021 |
| Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases UD Daimary, D Parama, V Rana, K Banik, A Kumar, C Harsha, ... Current Research in Pharmacology and Drug Discovery 2, 100008, 2021 | 28 | 2021 |
| Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review E Verma, A Kumar, UD Daimary, D Parama, S Girisa, G Sethi, ... Journal of Functional Foods 86, 104660, 2021 | 24 | 2021 |
| From simple mouth cavities to complex oral mucosal disorders—Curcuminoids as a promising therapeutic approach S Girisa, A Kumar, V Rana, D Parama, UD Daimary, S Warnakulasuriya, ... ACS pharmacology & translational science 4 (2), 647-665, 2021 | 24 | 2021 |
| Exploring the Cytotoxic Effects of the Extracts and Bioactive Triterpenoids from Dillenia indica against Oral Squamous Cell Carcinoma: A Scientific Interpretation … M Aswathy, K Banik, D Parama, P Sasikumar, C Harsha, AG Joseph, ... ACS pharmacology & translational science 4 (2), 834-847, 2021 | 22 | 2021 |
| An overview of the pharmacological activities of scopoletin against different chronic diseases D Parama, S Girisa, E Khatoon, A Kumar, MS Alqahtani, M Abbas, G Sethi, ... Pharmacological Research 179, 106202, 2022 | 18 | 2022 |
| Reiterating the Emergence of Noncoding RNAs as Regulators of the Critical Hallmarks of Gall Bladder Cancer V Rana, D Parama, E Khatoon, S Girisa, G Sethi, A Kunnumakkara Biomolecules 11 (12), 1847, 2021 | 17 | 2021 |
| The Promising Potential of Piperlongumine as an Emerging Therapeutics for Cancer ABK Dey Parama, Varsha Rana, Sosmitha Girisa, Elika Verma, Uzini Devi ... Explor Target Antitumor Ther, 2021 | 15* | 2021 |
| Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy E Khatoon, D Parama, A Kumar, MS Alqahtani, M Abbas, S Girisa, G Sethi, ... Life Sciences 306, 120827, 2022 | 14 | 2022 |
| Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer S Girisa, D Parama, C Harsha, K Banik, AB Kunnumakkara Exploration of Targeted Anti-tumor Therapy 1 (5), 313, 2020 | 14 | 2020 |
